First-line Avelumab Treatment for Stage IV Metastatic Merkel Cell Carcinoma
This preplanned interim analysis of a single-arm clinical trial evaluates the efficacy and safety of avelumab as first-line treatment for patients with distant metastatic Merkel cell carcinoma.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου